Found 51 matching trials
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC NA Non-resectable stage III non-small cell lung cancer is recommended for conc...
Show More Location
Affiliated Hospital of Guizhou Medical University
Learn More & Join Trial
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma PHASE1 This is the first study to evaluate the safety and clinical activity of the...
Show More Location
UCSF Benioff Children's Hospital, Oakland
Learn More & Join Trial
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck PHASE2 This research study is for subjects with squamous cell cancer of the head a...
Show More Location
USC/Norris Comprehensive Cancer Center
Learn More & Join Trial
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. PHASE1 Trial Objectives:
The objective is to investigate the efficacy and safety ...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer PHASE1 This study study aims to elucidate the immune responses to a shared antigen...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma PHASE2 This phase II trial tests the safety and effectiveness of glofitamab given ...
Show More Location
University of California, Davis
Learn More & Join Trial
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease PHASE1 A recombinant AAV vector has been generated to carry the codon-optimized ac...
Show More Location
Clinical and Translational Research Building (CTRB), University of Florida
Learn More & Join Trial
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy PHASE2 This randomized pilot phase II trial studies how well molecular phenotyping...
Show More Location
Case Comprehensive Cancer Center
Learn More & Join Trial
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction PHASE2 This is a phase II, multicenter, randomized, open-label study designed to e...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial